N.B.: Different languages can express different contents  -  (Italiano  English)


European Commissioner for Health and Food Safety Meets with Endocrine Society Members on Endocrine-Disrupting Chemicals (2016-03-21)

Society makes strong case for prioritization of Endocrine-Disrupting Chemicals as a public health threat.
Vytenis Andriukaitis, MD, the European Commissioner for Health and Food Safety, hosted members of the Endocrine Society who offered their scientific expertise with comments and concerns regarding the European Commission’s process to develop criteria to identify endocrine disruptors. An endocrine-disrupting chemical (EDC) is a chemical or mixture of chemicals in the environment that can interfere with any aspect of hormone action.

Society members Jean-Pierre Bourguignon, MD, PhD, Rémy Slama, PhD, and Leonardo Trasande, MD shared highlights from the Endocrine Society’s new Scientific Statement demonstrating that Endocrine-Disrupting Chemicals are an important public health threat, and that governments need to design regulations to protect vulnerable populations from irreversible effects.
Furthermore, they emphasized the significant costs of inaction, inadequate action, or improper regulation of Endocrine-Disrupting Chemicals.
Recent studies have shown that health effects from EDC exposure cost the EU more than €157 billion each year.

The Society previously weighed in on the EU Roadmap options for identifying EDCs, and the Society’s representatives discussed science-based criteria for the definition of EDCs and explained why potency cutoffs are inconsistent with endocrine science and are unsuitable for hazard characterization.
The Society supports the Roadmap option 3 which does not include potency as a criterion and offers a multi-level categorization based on level of evidence.

The Society is deeply concerned about the impact seen in patients’ lives that are increasingly linked to exposure to endocrine disrupting chemicals.

The Endocrine Society will continue to contribute scientific expertise to the EU’s efforts to ensure that the end result of EDC identification and subsequent regulatory process will effectively protect the public’s health.

For more information
Endocrine Society